NOTICE: The Taxi stand/drop-off point at the Medical Centre will be closed on November/December 24. Alternative drop-off locations are available at the Medical Centre (after the carpark gantry) or at the Main Lobby of Mount Elizabeth Hospital.

Dr. Tanujaa Rajasekaran

Medical Oncology (Cancer)

Language English, Tamil
Info

Dr Tanujaa Rajasekaran is a Senior Consultant, Medical Oncologist at Parkway Cancer Centre. She is experienced in general medical oncology, with subspecialty interests in the management of lung, genitourinary, breast cancerhead and neck cancers and geriatric oncology.

Prior to joining Parkway Cancer Centre, Dr Tanujaa served as a Consultant at National Cancer Centre Singapore and as the Medical Director of the Changi General Hospital oncology unit.

She graduated from National University of Singapore (NUS) and was awarded the Dean’s list during her undergraduate studies in 2006. Thereafter, she obtained her postgraduate qualifications – Masters of Medicine (Internal Medicine) from NUS, and her Membership of the Royal College of Physicians (UK). Subsequently, she went on to complete her specialist training in Medical Oncology in the National Cancer Centre Singapore.

Dr Tanujaa Rajasekaran is actively involved in medical education. She was a core faculty member of the Medical Oncology Senior Residency Program, as well as a Clinical lecturer at Yong Loo Lin School of Medicine, NUS. She was also an Assistant Professor at Duke NUS medical school. She has also published in a number of internationally renowned journals.

Dr Tanujaa is a member of several professional bodies, including the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) and International Society of Geriatric Oncology (SIOG). She is also Singapore’s National representative for SIOG.

Dr Tanujaa Rajasekaran has received numerous awards including Singapore Health Quality Service Awards in 2019 and 2022 as well as the European Society of Medical Oncology (ESMO) fellowship grant for her research in geriatric oncology.